By Abigail Townsend
Date: Wednesday 07 May 2025
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Currency | US Dollars |
Share Price | $ 769.70 |
Change Today | $ 6.97 |
% Change | 0.91 % |
52 Week High | $960.02 |
52 Week Low | $713.71 |
Volume | 1,366,200 |
Shares Issued | 948.17m |
Market Cap | $729,806m |
Beta | 0.70 |
RiskGrade | 179 |
Strong Buy | 11 |
Buy | 10 |
Neutral | 5 |
Sell | 1 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
11:31 | 106 @ $769.70 |
11:31 | 100 @ $769.80 |
11:31 | 100 @ $769.77 |
11:31 | 100 @ $769.80 |
11:31 | 100 @ $769.80 |
You are here: research